$-0.17
(Market cap
$1,340 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
0.1
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-3.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-458.8
-
Face value
--
-
Shares outstanding
59,162,294
6 Years Aggregate
CFO
$-303.39 Mln
EBITDA
$-336.77 Mln
Net Profit
$-336.35 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vor Biopharma (VOR)
| 71.9 | 3.1 | 50.2 | -42.9 | -24.5 | -40.6 | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Vor Biopharma (VOR)
| -41.1 | -50.4 | -66.2 | -42.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vor Biopharma (VOR)
|
22.5 | 1,340.0 | 0.0 | 627.8 | -- | -- | 0.1 | 0.7 |
| 82.4 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 70.9 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.6 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 106.5 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 359.4 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 594.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 350.3 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 147.8 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Vor Biopharma (VOR)
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia... gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Read more
-
President, CEO & Director
Dr. Robert Ang M.B.A., M.D., MBBS
-
President, CEO & Director
Dr. Robert Ang M.B.A., M.D., MBBS
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Vor Biopharma (VOR)
What is the current share price of Vor Biopharma Inc (VOR) Today?
The share price of Vor Biopharma Inc (VOR) is $22.48 (NASDAQ) as of 31-Aug-2026 16:02 EDT. Vor Biopharma Inc (VOR) has given a return of -24.48% in the last 3 years.
What is the current PB & PE ratio of Vor Biopharma Inc (VOR)?
The P/E ratio of Vor Biopharma Inc (VOR) is 0.13 times as on 28-Aug-2026.
The P/B ratio of Vor Biopharma Inc (VOR) is 0.66 times as on 28-Aug-2026, a 87 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.19 |
-0.79 |
2024 |
-0.03 |
0.04 |
2023 |
-0.06 |
0.05 |
2022 |
-0.17 |
0.06 |
2021 |
-0.31 |
0.10 |
What is the 52 Week High and Low of Vor Biopharma Inc (VOR)?
The 52-week high and low of Vor Biopharma Inc (VOR) are Rs 49.95 and Rs 6.50 as of 01-Sep-2026.
What is the market cap of Vor Biopharma Inc (VOR)?
Vor Biopharma Inc (VOR) has a market capitalisation of $ 1,340 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vor Biopharma Inc (VOR)?
Before investing in Vor Biopharma Inc (VOR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.